- Home
- AWX vs MYNZ Comparison
AWX vs MYNZ Comparison
Compare AWX & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWX
- MYNZ
- Stock Information
- Founded
- AWX 1998
- MYNZ 2021
- Country
- AWX United States
- MYNZ Germany
- Employees
- AWX N/A
- MYNZ 71
- Industry
- AWX Environmental Services
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- AWX Utilities
- MYNZ Health Care
- Exchange
- AWX Nasdaq
- MYNZ Nasdaq
- Market Cap
- AWX 13.6M
- MYNZ 10.7M
- IPO Year
- AWX 1998
- MYNZ 2021
- Fundamental
- Price
- AWX $3.48
- MYNZ $4.51
- Analyst Decision
- AWX
- MYNZ Hold
- Analyst Count
- AWX 0
- MYNZ 2
- Target Price
- AWX N/A
- MYNZ N/A
- AVG Volume (30 Days)
- AWX 16.1K
- MYNZ 131.6K
- Earning Date
- AWX 11-08-2024
- MYNZ 10-21-2024
- Dividend Yield
- AWX N/A
- MYNZ N/A
- EPS Growth
- AWX N/A
- MYNZ N/A
- EPS
- AWX 0.25
- MYNZ N/A
- Revenue
- AWX $83,487,000.00
- MYNZ $917,203.00
- Revenue This Year
- AWX N/A
- MYNZ $21.95
- Revenue Next Year
- AWX N/A
- MYNZ $30.77
- P/E Ratio
- AWX $13.95
- MYNZ N/A
- Revenue Growth
- AWX N/A
- MYNZ 16.23
- 52 Week Low
- AWX $2.00
- MYNZ $0.18
- 52 Week High
- AWX $3.99
- MYNZ $7.95
- Technical
- Relative Strength Index (RSI)
- AWX 46.40
- MYNZ 53.48
- Support Level
- AWX $3.32
- MYNZ $4.45
- Resistance Level
- AWX $3.69
- MYNZ $5.09
- Average True Range (ATR)
- AWX 0.25
- MYNZ 0.74
- MACD
- AWX -0.04
- MYNZ -0.08
- Stochastic Oscillator
- AWX 31.76
- MYNZ 32.04
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.